Injection Pen Market 2019 fueling growth and Rising prevalence in chronic diseases, ongoing technological advancements, and improving regulatory framework In-depth Analysis by Novo Nordisk, Eli Lilly, Sanofi, Merck, Ypsomed, AstraZeneca, F.Hoffman-La Roch

Injection Pen Market Outlook 2019 to 2040

According to International Diabetes Federation, in 2016, it was estimated that 420 million adult population were suffering from diabetes which is increasing at the rate of 8.4% and is expected to reach 625 million by 2040.

Furthermore, the increasing application of injection pen in the treatment of various chronic diseases, lifestyle diseases and infertility problems enhance the market growth. Additionally, in November 2017, Merck announced the approval of its new GONAL-f RFF Redi-ject (follitropin alfa injection) prefilled pen by the U.S. FDA.

Inquire for Sample Research Report https://www.marketresearchfuture.com/sample_request/6146

The global injection pen market is segmented on the basis of the type, product, therapy, distribution channel, and end users.


On the basis of the type, the market is classified into

disposable injection pens
and reusable injection pens

The global injection pen market on the basis of product is segmented into

insulin pens
and pen needles

On the basis of the therapy, the market is segmented as

diabetes,
growth hormone therapy,
fertility, osteoporosis,
multiple sclerosis,
cardiovascular diseases,
rheumatoid arthritis,
obesity,
Crohn's disease,
cancer,
and others

Diabetes is further segmented into

insulin
and GLP-1

On the basis of distribution channel is segmented into

hospital pharmacies,
retail pharmacies,
online medical stores,
and diabetes clinics.

On the basis of end users, the global injection pen market is segmented into home care and hospitals & clinics.

Some the prominent players in the global injection pen market are Novo Nordisk (Denmark), Eli Lilly (U.S.), Sanofi (France), Merck (U.S.), Ypsomed (Switzerland), AstraZeneca (U.K.), F.Hoffman-La Roche (Switzerland), Becton Dickinson and Company (US), Owen Mumford (U.K.), Novartis (Switzerland), Pfizer (U.S.), Haselmeier (Switzerland), Jiangsu Delfu medical device Co. Ltd (China), and Biocon Ltd (India).

Injection pen manufacturing companies
Original equipment manufacturing companies
Suppliers and distributors of injection pen
Healthcare service providers
Teaching hospitals and academic medical centers
Health insurance players
Government bodies/municipal corporations
Regulatory bodies
Medical research institutes
Browse Complete Premium Research Report https://www.marketresearchfuture.com/reports/injection-pen-market-6146

The Americas is likely to dominate the global injection pen market owing to the increasing prevalence of cancer and diabetes in the population during the forecast period. In addition, well-established healthcare sector, favorable reimbursement scenario, and growing number of regulatory approvals further drive the growth of the market. According to the WHO, in 2016, 9.6% of total America population were suffering from diabetes.

Europe is likely to hold the second position in the global injection pen market. The market growth is attributed to the availability of funds for research, increasing prevalence and government support for research and development.

The Asia Pacific is the fastest growing market owing to the huge patient pool with chronic diseases and increasing healthcare expenditure. For instance, according to the WHO (2016), in China, 10% of adults were diagnosed with diabetes. It also stated that type 2 diabetes was found to be the most prevalent type of diabetes in China.

The Middle East and Africa injection pen market are expected to grow slowly during the forecast period. Moreover, in this region, Middle East accounts for largest share owing to the increasing presence of prominent market players in the recent years.

Avail Discount at https://www.marketresearchfuture.com/check-discount/6146

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.